We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMHC
526
DELISTED
Taylor Morrison
TMHC
| $11.3M | 0.03% |
204,270
+3,803
| +2% | +$217K |
|
527
Merchants Bancorp
MBIN
$2.43B
| $11.3M | 0.03% |
277,912
-14,016
| -5% | -$575K |
|
|
CNR
528
Core Natural Resources Inc
CNR
$4.72B
| $11.3M | 0.03% |
110,341
-1,453
| -1% | -$132K |
|
529
Vulcan Materials
VMC
$32.2B
| $11.2M | 0.03% |
45,219
-17,033
| -27% | -$4.4M |
|
530
Procept Biorobotics
PRCT
$1.11B
| $11.2M | 0.03% |
183,420
+162,785
| +789% | +$9.68M |
|
531
Penumbra
PEN
$12.6B
| $11.1M | 0.03% |
61,741
-9
| -0% | -$1.8K |
|
532
Builders FirstSource
BLDR
$6.58B
| $11.1M | 0.03% |
79,894
+14,001
| +21% | +$2.38M |
|
533
Terex
TEX
$6.84B
| $11M | 0.03% |
199,824
-3,680
| -2% | -$218K |
|
534
Palantir
PLTR
$415B
| $10.9M | 0.03% |
431,667
+1,321
| +0.3% | +$29.7K |
|
535
American International
AIG
$39.9B
| $10.9M | 0.03% |
146,901
-3,286
| -2% | -$251K |
|
536
Mettler-Toledo International
MTD
$27.7B
| $10.7M | 0.03% |
7,667
+717
| +10% | +$981K |
|
537
AppFolio
APPF
$7.89B
| $10.7M | 0.03% |
43,754
-10,064
| -19% | -$2.34M |
|
538
Bruker
BRKR
$9.23B
| $10.6M | 0.03% |
166,561
+8,346
| +5% | +$628K |
|
539
Collegium Pharmaceutical
COLL
$737M
| $10.6M | 0.03% |
329,466
-65
| -0% | -$2.25K |
|
|
AVDX
540
DELISTED
AvidXchange
AVDX
| $10.6M | 0.03% |
878,773
-1,023
| -0.1% | -$11.7K |
|
541
Unilever
UL
$135B
| $10.6M | 0.03% |
171,085
-593,509
| -78% | -$35.1M |
|
542
Regal Rexnord
RRX
$10.2B
| $10.6M | 0.03% |
78,131
-50,735
| -39% | -$7.89M |
|
543
Mitsubishi UFJ Financial
MUFG
$265B
| $10.5M | 0.03% |
975,661
+146,904
| +18% | +$1.49M |
|
544
Vera Therapeutics
VERA
$2.28B
| $10.5M | 0.02% |
+290,000
| New | +$11.5M |
|
|
EXAS
545
DELISTED
Exact Sciences
EXAS
| $10.5M | 0.02% |
247,491
-310,740
| -56% | -$17.1M |
|
546
Novartis
NVS
$264B
| $10.4M | 0.02% |
97,936
-12,266
| -11% | -$1.23M |
|
547
Coca-Cola Consolidated
COKE
$13.4B
| $10.4M | 0.02% |
95,440
-78,460
| -45% | -$7.26M |
|
548
Pembina Pipeline
PBA
$27.8B
| $10.3M | 0.02% |
277,627
-14,435
| -5% | -$522K |
|
549
Broadridge
BR
$19.1B
| $10.3M | 0.02% |
52,129
-1,486
| -3% | -$295K |
|
550
Qualys
QLYS
$6.27B
| $10.2M | 0.02% |
71,356
+7,976
| +13% | +$1.21M |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.